← 홈

Antibody · 혈액암 (AML/ALL)

286개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 286개
AntibodystaleRochePhase 2

Bendamustine, Rituximab, Lenalidomide (Bendamustine, Rituximab, Lenalidomide)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Bevacizumab + Pemetrexed (Bevacizumab + Pemetrexed)

Non-squamous Non-small Cell Lung Cancer · Non-squamous Non-small Cell Lung Cancer

#Non-squamousNon-smallCellLungCan#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Bevacizumab + Pemetrexed + Carboplatin (Bevacizumab + Pemetrexed + Carboplatin)

Non-squamous Non-small Cell Lung Cancer · Non-squamous Non-small Cell Lung Cancer

#Non-squamousNon-smallCellLungCan#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab + modified FOLFIRINOX (Bevacizumab + modified FOLFIRINOX)

Mucinous Ovarian Cancer; Fallopian Tube Cancer · Mucinous Ovarian Cancer

#MucinousOvarianCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab Biosimilar HLX04 (Bevacizumab Biosimilar HLX04)

Non-Squamous Non-Small Cell Lung Cancer · Non-Squamous Non-Small Cell Lung Cancer

#Non-SquamousNon-SmallCellLungCan#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab plus erlotinib (Bevacizumab plus erlotinib)

Carcinoma, Non-Small-Cell Lung; Brain Neoplasms · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab, Oxaliplatin, Pemetrexed (Bevacizumab, Oxaliplatin, Pemetrexed)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleNational Cancer Center, KoreaPhase 2

nivolumab (Opdivo, CA and Nivolumab)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleFamewave Ltd.Phase 2

nivolumab (Opdivo, CM-24 and Nivolumab - Dose Escalation)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleFamewave Ltd.Phase 2

nivolumab (Opdivo, CM-24, Nivolumab, Nab paclitaxel and Gemcitabine - Expansion)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleFamewave Ltd.Phase 2

nivolumab (Opdivo, CM-24, Nivolumab, and Nal-IRI/5-FU/LV - Expansion)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleCorvus Pharmaceuticals, Inc.Phase 1

pembrolizumab (Keytruda, CPI-006 + pembrolizumab)

Non-Small Cell Lung Cancer; Renal Cell Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleIntergroupe Francophone de Canc…Phase 2

durvalumab (Imfinzi, Carboplatin + Paclitaxel + Durvalumab)

Small Cell Lung Cancer Extensive Stage · Small Cell Lung Cancer Extensive Stage

#SmallCellLungCancerExtensiveStag#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleVerastem, Inc.Phase 2

pembrolizumab (Keytruda, Carboplatin + Pemetrexed + Pembrolizumab)

Pancreatic Ductal Adenocarcinoma; Non Small Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma

#PancreaticDuctalAdenocarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Carboplatin and nab-paclitaxel plus atezolizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Carboplatin and paclitaxel plus atezolizumab and bevacizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePreclinical

atezolizumab (Tecentriq, Carboplatin/Cisplatin -Etoposide - Atezolizumab)

Small Cell Lung Cancer; Large Cell Neuroendocrine (NE) Tumors · Small Cell Lung Cancer

#SmallCellLungCancer#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 1

Cetuximab + Gefitinib (Cetuximab + Gefitinib)

Non-Small-Cell Lung Carcinoma · Non-Small-Cell Lung Carcinoma

#Non-Small-CellLungCarcinoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPreclinical

Cetuximab + RT (Cetuximab + RT)

Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck; LA SCCHN · Unresectable Locally Advanced Squamous C

#UnresectableLocallyAdvancedSquam#Antibody#Preclinical#항체#면역항체+3
효능 ORR 100%임상시험 1상태 DISCONTINUED
AntibodystaleEli LillyPhase 2

Cetuximab + platinum + gemcitabine (Cetuximab + platinum + gemcitabine)

Non-Small-Cell Lung Carcinoma · Non-Small-Cell Lung Carcinoma

#Non-Small-CellLungCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

6 / 15 페이지

← 이전다음 →